Common GLP-1 receptor agonist medications include semaglutide drugs such as Ozempic, Wegovy, and Rybelsus, as well as tirzepatide medications including Mounjaro and Zepbound
A formula with 60 diverse strains and 60 billion CFU covers broad spectrum support.* Introduce a prebiotic fiber supplement, starting at half the recommended serving
Only male participants are enrolled to reduce sex-related biological heterogeneity, which may limit the generalizability of the findings to female populations
Our personalized weight loss program includes: Compounded Semaglutide and Tirzepatide: Customized formulations based on your specific health profile
Sports 9(1):12 Funding Open access funding provided by Universit degli Studi di Torino within the CRUI-CARE Agreement
Tirzepatide produces superior, sustained weight loss in clinical trialsup to 22% body weight reduction over 68 weekscompared to phentermine's typical 5-10% loss over 12 weeks